Publicaciones en las que colabora con MARIA DOLORES BOYANO LOPEZ (20)

2023

  1. A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma

    Life, Vol. 13, Núm. 1

  2. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  3. Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients

    Cancers, Vol. 15, Núm. 7

  4. Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression

    Scientific Reports, Vol. 13, Núm. 1

2022

  1. Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis

    Life, Vol. 12, Núm. 12

  2. MGRN1 as a Phenotypic Determinant of Human Melanoma Cells and a Potential Biomarker

    Life, Vol. 12, Núm. 8

2020

  1. Analyzing the Immune Response of Neoepitopes for Personalized Vaccine Design

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  2. BRAF V600E mutational load as a prognosis biomarker in malignant melanoma

    PLoS ONE, Vol. 15, Núm. 3

  3. RKIP regulates differentiation-related features in melanocytic cells

    Cancers, Vol. 12, Núm. 6, pp. 1-22

2016

  1. Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin

    Biology of Sex Differences, Vol. 7, Núm. 1

2015

  1. Comparison of the transcriptional profiles of melanocytes from dark and light skinned individuals under basal conditions and following ultraviolet-B irradiation

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma

    PLoS ONE, Vol. 9, Núm. 4

  2. The Interplay between natural selection and susceptibility to melanoma on allele 374F of SLC45A2 gene in a south European population

    PLoS ONE, Vol. 9, Núm. 8

2011

  1. A customized pigmentation snp array identifies a novel snp associated with melanoma predisposition in the slc45a2 gene

    PLoS ONE, Vol. 6, Núm. 4

2010

  1. The diversity profile of TP53 is influenced by positive selection on the immediately upstream locus WDR79

    Human Heredity, Vol. 69, Núm. 1, pp. 34-44

2008

  1. Complex signatures of selection for the melanogenic loci TYR, TYRP1 and DCT in humans

    BMC Evolutionary Biology, Vol. 8, Núm. 1

2001

  1. Effect of IL-2 and IL-6 on parameters related to metastatic activity in a murine melanoma

    Pathobiology, Vol. 69, Núm. 4, pp. 230-236

1998

  1. Cyclosporin A upmodulates the α-subunit of the interleukin-2 receptor and the metastatic ability of murine B16F10 melanoma cells

    Invasion and Metastasis, Vol. 18, Núm. 3, pp. 122-133

1996

  1. Expression of IL-2 receptor beta-chain in B16 melanoma cells.

    The International journal of developmental biology, Vol. Suppl 1

  2. Serum interleukin-6 levels in patients with melanoma.

    The International journal of developmental biology, Vol. Suppl 1